Researchers Use Data to Identify Different Forms of Prostate Cancers and Effective Treatment Options
News Medical - May 24, 2013
Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease. Researchers at Case Western Reserve University and Johns Hopkins Medical Institutes are developing technology that allows patients to safely choose to do nothing, opt for relatively mild treatments or take drastic measures. The project is one of several Anant Madabhushi, an associate professor of biomedical engineering at Case Western Reserve and director of the Center for Computational Imaging and Personalized Diagnostics, is involved in.
Five Star Sensation helps fund University Hospitals Seidman Cancer Center
News Herald - May 23, 2013
Dr. Stan Gerson, director of the UH Seidman Cancer Center, said clinical trials and survivorship programs are especially valuable contributions made possible with the money raised by Five Star Sensation, because they often are not covered by patient insurance.
ASCO Annual Meeting 2013
The Case CCC is pleased to have many members participating in the American Society of Clinical Oncology (ASCO) Annual Meeting, May 31-June 4 in Chicago. To view a list of Cancer Center participation, please click here. We encourage members who are attending the meeting to support their colleagues.
Best of luck to all participants!
Dr. Mikkael Sekeres Named FDA ODAC Chair for Another Term
Mikkael Sekeres, MD, MS, Leukemia Program Director, Cleveland Clinic Taussig Cancer Institute, will remain Chair of the Oncologic Drugs Advisory Committee (ODAC) of the Food and Drug Administration (FDA) for another year. The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer and makes appropriate recommendations to the Commissioner of Food and Drugs. Dr. Sekeres has been a voting member of this Committee for the past three years.
Request for Information: Opportunities for Cancer-relevant Innovative Technologies with Transformative Potential
The NCI is looking for feedback from cancer researchers, clinicians, and other interested members of the community through a Request for Information (RFI). The purpose of the RFI is to seek input on the most important needs and promising opportunities to develop technologies with strong potential for accelerating cancer research or clinical care. NCI is interested in understanding the communities' perspective on areas where state-of-the-art capabilities are insufficient for clinical care or to explore biological or epidemiological facets of cancer. Responses to the RFI will be used for consideration of research priorities and may help to develop future funding opportunities. Please respond by June 30, 2013.
Race for the Place- Join Our Team!
The Race for the Place, an event that benefits the Gathering Place, will be held Sunday, June 2 at Beachwood Place Mall. The Case CCC has created a team. Click here to join the team or to show your support by making a donation. Contact Gillian Todd for more information.
Impact of Genomics on Cancer Diagnosis and Treatment: Open Drug Policy Forum
The Case CCC, in partnership with five other Midwest comprehensive cancer centers, will convene a public forum on the emerging revolution in genetic testing known as precision or personalized medicine on Monday, June 10. Experts from the FDA, NCI, CMS, pharmaceutical industry, public health sector, and the cancer research community will participate in dynamic lectures and discussions to consider the complexities of integrating genetic testing into cancer care.
This forum is free and open to the public. Pre-registration required: http://goo.gl/xEuwA.
More information is on the Cancer Center site.
Complying with the NIH Public Access Policy
Staff from the CWRU Cleveland Health Sciences Library will present, Complying with the NIH Public Access Policy, onFriday, June 14 from 9-10:15 am in the Wolstein Research Building Auditorium. This seminar will facilitate compliance with the "Revised Policy on Enhancing Public Access to Archived Publications Resulting from NIH-Funded Research." They will outline the submission process and services available on campus to assist researchers in complying with the policy, which requires that all peer-reviewed manuscripts accepted for publication after April 7, 2008, and resulting fully or in part from NIH-funded research, must be deposited to PubMed Central within twelve months of publication. In addition, these articles must be associated with the NIH grant(s) in NCBI's MyBibliography.
Limited Submission: Hartwell Foundation – Individual Biomedical Research Awards
CWRU earned an at-large bid in The Hartwell Foundation's Individual Biomedical Research Awards program, and is eligible to nominate two faculty members for proposal submission this year. The foundation funds 10 Hartwell Investigators annually for their innovative, early-stage, cutting-edge biomedical research that has the potential to benefit children.
Internal Deadline: June 17
Internal Application Deadline: July 19
External Deadline: September 16
Request for Proposals for Case CCC Funding for Pilot/Phase I Clinical Trials
The Case CCC is encouraging investigators to submit Letters of Intent for Early Phase Clinical Research Support (EPCRS; former Protocol Specific Research Support) funding. These in-house funds are available for the conduct of early phase clinical trials of relatively short duration. Priority will be given to trials which are developed jointly between UH and CCF with planned accrual at both institutions. (See revised NCI Cancer Center Support Grant EPCRS guidelines, page 43, Section 2.12).
Please submit LOIs and direct questions about the revised guidelines and funding process to Katarzyna Karelus, Case CCC Clinical Research Office, firstname.lastname@example.org, 216-844-4176.
Deadline: July 15
DOD Lung Cancer Research Program
Applications to the Fiscal Year 2013 Lung Cancer Research Program (LCRP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program, by the U.S. Army Medical Research Acquisitions Activity.
DOD Peer Reviewed Cancer Research Program (PRCRP)
Applications to the Fiscal Year 2013 Peer Reviewed Cancer Research Program (PRCRP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program, by the U.S. Army Medical Research Acquisitions Activity.
Alex's Lemonade Stand Foundation
Alex's Lemonade Stand Foundation (ALSF) is accepting applications for the following funding opportunities:
American Gastroenterological Association Funderburg Research Award in Gastric Cancer
The American Gastroenterological Association is accepting applications for the Funderburg Research Award in Gastric Cancer. This award provides support to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in the diagnosis or treatment of gastric carcinoma.
Deadline: August 30
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Chris4Life Colon Cancer Pilot Study Grant Program
OCRP Resource Development Award
Case CCC Protocol Specific Research Support (PSRS)
International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.
Happy Memorial Day!
Molecular Genetics Departmental Seminar
Graduate Student, Runge Lab, Molecular Genetics
9:30 am NE1-205 Cleveland Clinic
Immunology Seminar Series
PhD Student, Boom Lab, Pathology
Topic: RA Synthesis in Lung APCs and Regulation by Mycobacterium Tuberculosis
12 pm BRB 105
Medicine Grand Rounds
Michael Bronze, MD
University of Oklahoma
Topic: Duty Hour Reform: Is the Beef There?
12 pm Kulas Auditorium, Lakeside 5th Fl.
National Center for Regenerative Medicine
Toshio Suda, MD
Former President ISEH
Professor, Developmental Biology, Sakaguchi Lab
Topic: Hematopoiesis Under the Stress
2 pm WRB 2-136
Hematology and Oncology Division Research Conference
Waqas Rehman, MD
Fellow, Div. of Hem/Onc
Topic: Identifying Novel Targets in Advanced Non-small Cell Lung Cancer
8 am Lerner B-151
Ohio Third Frontier Scientific Open Forum
8:30 am - 12 pm WRB 1-413
Hematology and Oncology Special Seminar
Robert Gale, MD, PhD
Visiting Professor, Div. of Experimental Medicine- Hematology
Topic: Medical Consequences of Nuclear Accidents
1 pm Wearn 137
Cancer Center Faculty Candidate Seminar
Rui Chen, PhD
Postdoctoral Scholar, Genetics
Topic: Towards Precision Medicine with Integrative Personal Omics Profiling
4 pm WRB 3-136
Taussig Cancer Institute Grand Rounds canceled
Hematology and Oncology Fellows Conference
8 am Wearn 137/Breen Conference Rm.
Cancer Center Research in Progress
4 pm WRB 3-136
Impact of Genomics on Cancer Diagnosis and Treatment: Open Drug Policy Forum
9 am - 3 pm Wolstein Research Building Auditorium
Annual Cancer Center Scientific Retreat
National GvHD Health Symposium